Cancer in the stomach or in the junction between the stomach and the oesophagus, without metastases in other organs and surgically resectable, with microsatellite instability and no EBV infection.

• Study on the combination of two immunotherapeutic agents as pre-surgical therapy or definitive treatment in patients with resectable gastric … Recruitment ended
  2024-518842-26-00 4 2025-01-21

Showing 1–1 of 1 trials